MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

12 hedge funds and large institutions have $277K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-7
Holders Change %
-36.84%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
5
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
IC
1
Ikarian Capital
Texas
$134K -$20.4K -66,320 -13%
BBHC
2
Brown Brothers Harriman & Co
New York
$54K
Renaissance Technologies
3
Renaissance Technologies
New York
$30K +$25.4K +82,175 +556%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$15K
BFM
5
Boothbay Fund Management
New York
$14K -$1.47K -4,607 -10%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$10K -$7.48K -23,183 -43%
Envestnet Asset Management
7
Envestnet Asset Management
Illinois
$7K +$1.63K +5,404 +30%
CAPTRUST Financial Advisors
8
CAPTRUST Financial Advisors
North Carolina
$5K
Two Sigma Advisers
9
Two Sigma Advisers
New York
$4K -$496 -1,700 -11%
Osaic Holdings
10
Osaic Holdings
Arizona
$3K +$139 +469 +5%
AA
11
AlphaMark Advisors
Kentucky
$1K
Citadel Advisors
12
Citadel Advisors
Florida
-$36K -141,226 Closed
VF
13
Virtu Financial
New York
-$25K -100,291 Closed
HighTower Advisors
14
HighTower Advisors
Illinois
-$14K -56,000 Closed
Millennium Management
15
Millennium Management
New York
-$10K -41,517 Closed
HF
16
HRT Financial
New York
-$9K -36,342 Closed
Two Sigma Investments
17
Two Sigma Investments
New York
-$3K -13,314 Closed